Transmission of HIV-Associated XDR TB in Rural South Africa
Transmission of HIV-Associated XDR TB in Rural South Africa
批准号:
8573287
负责人:
Neel Rajnikant Gandhi
金额:
$55.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-15 至 2015-03-31
关键词:
14 year oldAddressAdherenceAdvisory CommitteesAffectAreaBacillus (bacterium)CD4 Lymphocyte CountChestCommunitiesContact TracingCountryCross-Sectional StudiesDataDiagnosisDiseaseDisease OutbreaksDrug Resistant TuberculosisDrug resistanceEarly DiagnosisEnrollmentEpidemicEpidemiologic StudiesEpidemiologyExposure toExtreme drug resistant tuberculosisFluoroquinolonesFutureGenotypeGoalsHIVHIV InfectionsHIV drug resistanceHealthHealth PolicyHealthcareHospital MortalityHospitalsImmunocompromised HostImmunosuppressionIndividualInfectionInfection ControlInjectableInterventionInvestigationKnowledgeLeadLinkLocationLung diseasesMalabsorption SyndromesMeasuresMethodsMolecularOutcomePathway AnalysisPatientsPatternPerceptionPersonsPharmaceutical PreparationsPlayPopulationPredispositionPrevalencePreventionProvincePublic HealthRelative (related person)ResearchResearch PriorityResistanceResourcesRifampinRisk FactorsRoleRuralSiteSocial NetworkSouth AfricaSputumTechniquesTestingTherapeuticTimeUnited States National Institutes of HealthWorkbasecommunity settingdisorder preventionevidence baseimprovedinsightisoniazidmortalitymutantnovelpopulation basedpressurepreventprogramsprospectivepublic health relevanceresponserural areasoundtransmission processtuberculosis drugstuberculosis treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Extensively drug-resistant tuberculosis (XDR TB) has emerged as a significant global epidemic and poses a particular threat to HIV-infected persons. Drug-resistant TB disease is predominantly thought to develop as a result of selection pressure for drug-resistant mutant bacilli ("amplified resistance"). Drug-resistant TB disease may also occur, however, from exposure to and infection with a TB strain which is already drug-resistant ("primary transmission"). Transmission of drug-resistant TB strains has been well-described in congregate settings, such as hospitals containing highly immunocompromised patients, but few studies have evaluated population-level transmission of drug-resistant TB, and none have done so in a high HIV prevalence setting. The collision of XDR TB and HIV in South Africa offers a unique, early opportunity to study these dual epidemics, which are anticipated to converge in other countries in the future. The current global crisis of drug-resistant TB is due to both amplified resistance and primary transmission, although the relative contribution of each is unknown. In Aim 1 of this application, we propose a prospective, population-based, cross-sectional study to determine the proportion of new XDR TB cases which develop due to primary transmission as opposed to amplified resistance in Tugela Ferry district, a rural area of South Africa with exceedingly high rates of XDR TB and HIV co-infection. We hypothesize that over three-quarters of XDR TB cases arise due to primary transmission. In Aim 2, we will combine molecular genotyping with contact tracing and social network analysis to provide insights into the relationships between XDR TB subjects with matching strain genotypes ("clusters") and the locations where TB transmission may be occurring. We expect to identify that transmission is occurring in not only healthcare, but also community congregate settings. The findings from this study will lead to a better understanding of XDR TB transmission patterns in the Tugela Ferry community, which is critical for targeting interventions to curb the ongoing XDR TB epidemic. The proposed study will be the first to integrate epidemiologic, molecular, and social network analytic methods to study TB transmission in a high HIV prevalence setting. The interactions between HIV infection and drug-resistant TB have been identified as a priority research area by the NIH and the Federal TB Task Force, specifically epidemiologic research and greater use of genotyping to improve understanding of HIV and drug-resistant TB, and implementation of intensive contact tracing and outbreak investigation. This application will address these issues directly and take place at the epicenter of the convergent epidemics of TB, HIV, and drug-resistant TB in rural South Africa, where our research group has been working since 2002. Continuous, population-level surveillance for XDR TB, including culture and drug-susceptibility testing for all TB suspects in Tugela Ferry district, creates a unique opportunity to study XDR TB transmission.
PUBLIC HEALTH RELEVANCE: Effective prevention of XDR TB, a disease characterized by extremely high mortality, especially in HIV-infected patients, is crucial to controlling the current epidemic and will require understanding patterns of transmission in both healthcare and community settings. This study, which combines classic contact investigation with advanced molecular epidemiologic techniques and social network analysis, will examine XDR TB transmission patterns in a high-HIV-prevalent, rural, resource-limited setting. Findings will help improve the health of individuals and communities affected by the XDR TB epidemic and will create an evidence-base to guide sound public health policy for XDR TB disease prevention throughout the developing world.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Emergence of bedaquiline, pretomanid and linezolid resistance after implementation of new drug-resistant tuberculosis regimens in South Africa
-
批准号:10606031
-
项目类别:
-
资助金额:$83.22万
-
财政年份:2022
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10429400
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2022
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10429399
-
项目类别:
-
资助金额:$98.64万
-
财政年份:2022
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10596164
-
项目类别:
-
资助金额:$97.23万
-
财政年份:2022
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10596165
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2022
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection
-
批准号:10208663
-
项目类别:
-
资助金额:$77.52万
-
财政年份:2018
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection
-
批准号:10433919
-
项目类别:
-
资助金额:$77.68万
-
财政年份:2018
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global Health
-
批准号:10625368
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2014
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global Health
-
批准号:9898222
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2014
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health
-
批准号:9064704
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2014
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health
-
批准号:8790305
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2014
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global Health
-
批准号:10159188
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2014
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global Health
-
批准号:10405506
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2014
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB
-
批准号:8289466
-
项目类别:
-
资助金额:$89.17万
-
财政年份:2010
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Transmission of HIV-Associated XDR TB in Rural South Africa
-
批准号:8636984
-
项目类别:
-
资助金额:$71.15万
-
财政年份:2010
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB
-
批准号:8103143
-
项目类别:
-
资助金额:$77.89万
-
财政年份:2010
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB
-
批准号:8521065
-
项目类别:
-
资助金额:$75.73万
-
财政年份:2010
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Transmission of HIV-Associated XDR TB in Rural South Africa
-
批准号:8452163
-
项目类别:
-
资助金额:$69.69万
-
财政年份:2010
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB
-
批准号:8012916
-
项目类别:
-
资助金额:$82.85万
-
财政年份:2010
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB
-
批准号:8696597
-
项目类别:
-
资助金额:$64.13万
-
财政年份:2010
-
负责人:Neel Rajnikant Gandhi
-
依托单位:
海外基金